Profile
DXR ISRG BDXA BDX ALC RMD
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $68.69M $192.04B $55.91B $53.26B $37.61B $37.14B
Employees 0.04K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Michael Richard Feldschuh Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
DXR ISRG BDXA BDX ALC RMD
Quant Rating Score 3 3 5 3 3 4
Quant Rating Neutral Neutral Strong Buy Neutral Neutral Buy
Trading
DXR ISRG BDXA BDX ALC RMD
Last Close $13.43 $537.59 $59.24 $181.52 $73.6 $253.62
High 52 $14.18 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $7.05 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High -5.29 % -11.94 % 0 % -27.12 % -25.13 % -13.66 %
Price vs. 52 Week Low 90.5 % 25.14 % 0 % 9.91 % 2.15 % 23.97 %
Total Return
DXR ISRG BDXA BDX ALC RMD
1 Month Return -2.43 % 20.2 % 0 % -3.02 % -1.21 % -7.35 %
3 Month Return 35.66 % 7.41 % 0 % -0.01 % -17.49 % -8.58 %
6 Month Return 82.04 % 4.05 % 0 % -12.35 % -24.69 % 7.09 %
9 Month Return 69.8 % -7.34 % 0 % -26.95 % -20.28 % -1.56 %
YTD Return 74.64 % 2.99 % 0 % -19.99 % -13.3 % 10.9 %
1 Year Return 50.9 % 4.64 % 0 % -23.28 % -21.09 % 4.36 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.26 % 2.24 % 0.44 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) -35008 % 4.3 % 1.73 % 1.73 % 3.26 % 4.34 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.19 %
Profitability
DXR ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 89.54 % 66.41 % 45.08 % 45.08 % 55.13 % 59.36 %
Return on Assets TTM 5.01 % 14.19 % 2.93 % 2.93 % 3.42 % 17.14 %
Return on Equity TTM 5.03 % 16.08 % 6.31 % 6.31 % 4.93 % 25.51 %
Return on Capital Employed TTM 5.39 % 16.05 % 5.78 % 5.78 % 4.98 % 23.55 %
Net Income Per EBT TTM 100 % 86.77 % 83.91 % 83.91 % 85.57 % 83.5 %
EBT Per Ebit TTM 92.85 % 112.41 % 70.86 % 70.86 % 86.96 % 99.54 %
EBIT Per Revenue TTM 271.25 % 29.3 % 12.63 % 12.63 % 14.38 % 32.75 %
Cash Flow To Debt Ratio TTM -13.31 % - 16.82 % 16.82 % 39.27 % 198.52 %
Receivables Turnover TTM 393.63 7.63 7.27 7.27 4.98 5.48
Payables Turnover TTM 16.09 11.09 1.85 1.85 5.03 7.52
Inventory Turnover TTM - 1.81 2.97 2.97 1.88 2.25
Fixed Asset Turnover TTM - 186.61 % 313.67 % 313.67 % 197.54 % 716.47 %
Asset Turnover TTM 1.99 % 49.67 % 38.95 % 38.95 % 31.94 % 62.96 %
Operating Cash Flow Per Share TTM -0.01 8.3 11.3 11.3 4.16 11.96
Free Cash Flow Per Share TTM -0.01 6.37 8.85 8.85 3.23 11.32
Cash Per Share TTM - 1376.56 % 262.85 % 262.85 % 284.33 % 825.72 %
Operating Cash Flow Sales Ratio TTM -4.91 % 30.8 % 15.22 % 15.22 % 20.57 % 34.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.01 % 76.72 % 78.37 % 78.37 % 77.51 % 94.7 %
Cash Flow Coverage Ratios TTM -13.31 % - 16.82 % 16.82 % 39.27 % 198.52 %
Price To Free Cash Flows Ratio TTM -1961.83 84.55 20.71 20.89 23.53 22.39
Price To Operating Cash Flows Ratio TTM -1962.02 64.75 16.3 16.45 18.27 21.21
Price Cash Flow Ratio TTM -1962.02 64.75 16.3 16.45 18.27 21.21
Income Statement (TTM)
DXR ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 100% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $0B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $0B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 0.11 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
DXR ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $0B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $0.04B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0.04B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $0B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $0.04B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
DXR ISRG BDXA BDX ALC RMD
Net Income $0B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $0B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.25
ANGO AngioDynamics, Inc. 12.135
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 124.26
ATRC AtriCure, Inc. 34.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.05
AZTA Azenta, Inc. 29.91
BAX Baxter International Inc. 19.175
BDX Becton, Dickinson and Company 179.285
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.155
BLFS BioLife Solutions, Inc. 26.91
COO The Cooper Companies, Inc. 70.1
EKSO Ekso Bionics Holdings, Inc. 5.09
FEMY Femasys Inc. 0.6185
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 334.17
VTSAX Vanguard Total Stock Market Index Fund 0.00003 164.31
VITSX Vanguard Total Stock Market Index Fund 0.00003 164.34
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 512.34
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 308.28
Unlock